Massive Postoperative Hemorrhage in PACU with AKI and Hypovolemic ShocK - Nursing Case Study
Pathophysiology
• Primary mechanism: Massive blood loss during or after surgery reduces circulating blood volume, leading to decreased tissue perfusion and oxygen delivery, which can result in hypovolemic shock.
• Secondary mechanism: The significant drop in blood volume activates compensatory mechanisms, like vasoconstriction and tachycardia, but if unresolved, it causes inadequate perfusion to the kidneys, potentially leading to Acute Kidney Injury (AKI) due to ischemia.
• Key complication: Hypovolemic shock exacerbates organ dysfunction, particularly affecting renal function, and can lead to systemic complications if not promptly managed, highlighting the critical need for rapid intervention in the PACU.
Patient Profile
Demographics:
45-year-old male, construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes Mellitus
• Current medications: Metformin, Lisinopril, Aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Severe abdominal pain and dizziness post-surgery
• Key symptoms: Decreased urine output, confusion, pallor, and sweating
• Vital signs: Blood pressure 85/60 mmHg, heart rate 120 bpm, respiratory rate 24 breaths per minute, temperature 37.2°C, oxygen saturation 90% on room air
Section 1
As the nursing team in the Post-Anesthesia Care Unit (PACU) continues to monitor the 45-year-old male patient, his condition shows signs of deterioration, prompting further assessment. The patient, who underwent surgery earlier, is experiencing severe abdominal pain and dizziness, classic indicators of hypovolemic shock. Notably, his blood pressure remains critically low at 85/60 mmHg despite initial fluid resuscitation, and his heart rate is persistently elevated at 120 bpm, suggesting ongoing compensatory mechanisms. Additionally, his oxygen saturation has dipped to 88% on room air, necessitating supplemental oxygen therapy to improve tissue oxygenation.
In response to these alarming findings, a series of diagnostic tests are conducted to better understand the extent of the complications. Laboratory results reveal a significant drop in hemoglobin levels to 7 g/dL, indicating substantial blood loss. Furthermore, kidney function tests show an increase in creatinine to 2.5 mg/dL and blood urea nitrogen (BUN) to 45 mg/dL, confirming the presence of Acute Kidney Injury (AKI) likely due to prolonged hypotension and reduced renal perfusion. The arterial blood gas analysis reflects a metabolic acidosis with a pH of 7.30, further emphasizing the systemic impact of the hypovolemic shock.
These findings highlight the urgency of addressing the root causes of the patient's instability. The immediate clinical focus is on optimizing hemodynamic support through aggressive fluid replacement and potential blood transfusion to restore adequate circulating volume and improve tissue perfusion. Additionally, the management plan includes close monitoring of renal function and vital signs to assess the effectiveness of interventions. The care team considers the possibility of additional complications, such as disseminated intravascular coagulation (DIC), given the patient's predisposition due to massive hemorrhage, necessitating vigilant observation for any signs of coagulopathy. This comprehensive approach aims to stabilize the patient's condition while preventing further systemic deterioration.
Section 2
As the PACU team continues to manage the patient, a sudden change in his condition signals the emergence of a new complication. Despite the administration of intravenous fluids and a transfusion of packed red blood cells, the patient’s blood pressure remains precariously low and his heart rate remains elevated. In addition to the existing signs of hypovolemic shock, the patient begins to exhibit petechiae on his chest and arms, along with oozing from the surgical incision site. These assessment findings raise concerns about the onset of disseminated intravascular coagulation (DIC), a condition characterized by widespread clotting and subsequent bleeding due to the consumption of clotting factors.
Prompted by these developments, the care team conducts a coagulation profile, which reveals a prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), along with a decreased platelet count of 80,000/µL. Fibrin degradation products are elevated, and D-dimer levels are markedly increased, confirming the diagnosis of DIC. In response, the clinical team initiates treatment with fresh frozen plasma and platelet transfusions to address the coagulopathy, while continuing to support the patient’s hemodynamic status.
As the team implements these interventions, they remain vigilant in monitoring for further signs of systemic instability. Continuous assessment of vital signs, urine output, and laboratory values is crucial in evaluating the patient's response to the treatment regimen. The evolving situation underscores the complexity of the case and emphasizes the need for meticulous clinical reasoning to navigate the challenges posed by DIC and its impact on the patient's recovery trajectory. The goal is to stabilize the patient's condition, prevent further complications, and ensure a path toward recovery while maintaining a keen awareness of potential changes that could necessitate additional interventions.
Section 3
As the patient continues to receive treatment in the PACU, the care team pays close attention to his response to the interventions aimed at managing DIC and stabilizing his hemodynamic status. Over the next few hours, the patient's vital signs show a slight improvement; his blood pressure inches upward to 92/58 mmHg, and his heart rate decreases to 108 beats per minute. Despite these encouraging signs, his urine output remains concerningly low at 20 mL over the last hour, indicating ongoing acute kidney injury (AKI) exacerbated by hypovolemia and DIC-related microvascular thrombosis. The team recognizes the need to balance aggressive fluid resuscitation with caution to avoid fluid overload, given the risk of acute pulmonary edema due to compromised renal function.
Laboratory results reveal further insights into the patient's condition: his serum creatinine has risen to 3.2 mg/dL from an admission value of 1.1 mg/dL, confirming the progression of AKI. Additionally, his hemoglobin level has dropped slightly to 8.5 g/dL, despite transfusions, suggesting continued bleeding and impaired erythropoiesis. In light of these findings, the team considers the need for renal replacement therapy if renal function does not improve soon. Concurrently, they assess for potential sources of ongoing bleeding or clotting, including a review of the surgical site and imaging studies to rule out retroperitoneal hemorrhage or other hidden sources.
Recognizing the multifactorial challenges in this case, the team plans to initiate a low-dose vasopressor infusion to support blood pressure while continuing to closely monitor the patient’s fluid status and coagulation parameters. They also consult nephrology and hematology specialists to optimize the management of AKI and DIC. This collaborative approach aims to prevent further deterioration, promote renal recovery, and address the underlying coagulopathy. The patient’s trajectory remains uncertain, and the team remains vigilant for any new complications that may arise, ready to adapt their management strategy as needed.
Section 4
As the care team continues to monitor the patient in the PACU, they notice a notable change in his status. Approximately six hours post-surgery, the patient begins to exhibit signs of respiratory distress. His respiratory rate increases to 28 breaths per minute, and he demonstrates accessory muscle use, indicative of labored breathing. Auscultation of the lungs reveals bilateral crackles, particularly at the bases, suggesting the development of pulmonary edema, a complication the team was vigilantly guarding against due to his compromised renal function and ongoing fluid resuscitation.
In response to these concerning respiratory findings, the team performs an immediate arterial blood gas (ABG) analysis, which reveals a pH of 7.31, PaCO2 of 48 mmHg, PaO2 of 62 mmHg, and HCO3 of 22 mEq/L, consistent with acute respiratory acidosis secondary to hypoxemia. Concurrently, a chest X-ray is ordered and reveals diffuse bilateral pulmonary infiltrates, further supporting the diagnosis of acute pulmonary edema. The patient's oxygen saturation has dropped to 88% on 4 liters of oxygen via nasal cannula, prompting the team to escalate respiratory support to high-flow nasal cannula therapy to improve oxygenation.
Given these developments, the team reassesses their management plan. The nephrology consult is expedited to discuss the timing of potential renal replacement therapy, which may help manage fluid overload and improve the patient's respiratory status. Hematology is also actively engaged to ensure anticoagulation and clotting factor replacement are optimized to balance the risk of bleeding with the need to manage DIC. The team adjusts the vasopressor infusion to maintain adequate perfusion pressure while carefully titrating fluids to avoid further exacerbation of pulmonary edema. This complex interplay of interventions highlights the critical need for dynamic clinical reasoning as the team works to stabilize the patient and prevent further complications.
Section 5
As the care team continues to manage the patient's delicate balance, a new complication arises. Approximately eight hours post-surgery, the patient experiences an abrupt change in mental status, becoming increasingly lethargic and difficult to arouse. A quick assessment reveals that his blood pressure has dropped to 80/50 mmHg, with a heart rate now tachycardic at 120 beats per minute. These vital signs indicate a potential worsening of hypovolemic shock, despite ongoing fluid resuscitation and vasopressor support. Concerned about cerebral perfusion, the team conducts a brief neurological assessment, which reveals a Glasgow Coma Scale (GCS) score of 10, down from 14 earlier.
In response to these alarming findings, the team promptly orders a repeat set of laboratory tests, including a complete blood count (CBC), electrolytes, lactate level, and coagulation profile. The results reveal a significant drop in hemoglobin to 6.5 g/dL, indicating ongoing blood loss, likely exacerbating the patient's shock state. The lactate level has risen to 4.5 mmol/L, suggesting worsening tissue hypoperfusion. Sodium and potassium levels remain stable, but the INR is elevated, confirming the presence of coagulopathy, likely due to disseminated intravascular coagulation (DIC) that had been previously suspected.
The care plan is urgently adjusted to address these new complications. The patient is transfused with packed red blood cells and fresh frozen plasma to manage the anemia and coagulopathy. The vasopressor dosage is carefully increased to stabilize blood pressure and improve cerebral perfusion. Nephrology is consulted again to assess the acute kidney injury's progression, as the possibility of initiating renal replacement therapy becomes more critical. The team remains vigilant, knowing that each intervention must be meticulously balanced to prevent further exacerbation of his complex condition, as they work towards stabilizing the patient and preventing irreversible organ damage.